A Review of Melatonin, Its Receptors and Drugs
Top Cited Papers
Open Access
- 22 July 2016
- journal article
- review article
- Published by AVES YAYINCILIK A.Ş. in Eurasian Journal of Medicine
- Vol. 48 (2), 135-141
- https://doi.org/10.5152/eurasianjmed.2015.0267
Abstract
After a Turkish scientist took Nobel Prize due to his contributions to understand clock genes, melatonin, closely related to these genes, may begin to shine. Melatonin, a hormone secreted from the pineal gland at night, plays roles in regulating sleep-wake cycle, pubertal development and seasonal adaptation. Melatonin has antinociceptive, antidepressant, anxiolytic, antineophobic, locomotor activity-regulating, neuroprotective, anti-inflammatory, pain-modulating, blood pressure-reducing, retinal, vascular, anti-tumor and antioxidant effects. It is related with memory, ovarian physiology, and osteoblast differentiation. Pathologies associated with an increase or decrease in melatonin levels are summarized in the review. Melatonin affects by four mechanisms: 1) Binding to melatonin receptors in plasma membrane, 2) Binding to intracellular proteins such as calmoduline, 3) Binding to Orphan nuclear receptors, and 4) Antioxidant effect. Receptors associated with melatonin are as follows: 1) Melatonin receptor type 1a: MT1 (on cell membrane), 2) Melatonin receptor type 1b: MT2 (on cell membrane), 3) Melatonin receptor type 1c (found in fish, amphibians and birds), 4) Quinone reductase 2 enzyme (MT3 receptor, a detoxification enzyme), 5) RZR/RORα: Retinoid-related Orphan nuclear hormone receptor (with this receptor, melatonin binds to the transcription factors in nucleus), and 6) GPR50: X-linked Melatonin-related Orphan receptor (it is effective in binding of melatonin to MT1). Melatonin agonists such as ramelteon, agomelatine, circadin, TIK-301 and tasimelteon are introduced and side effects will be discussed. In conclusion, melatonin and related drugs is a new and promising era for medicine. Melatonin receptors and melatonin drugs will take attention with greater interest day by day in the future.This publication has 53 references indexed in Scilit:
- Melatonin Receptor Genes in VertebratesInternational Journal of Molecular Sciences, 2013
- MELATONIN DEFICIENCY AND DISRUPTED CIRCADIAN RHYTHMS IN PEDIATRIC SURVIVORS OF CRANIOPHARYNGIOMANeurology, 2009
- Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatoninBritish Journal of Clinical Pharmacology, 2007
- Clock genes: influencing and being influenced by psychoactive drugsTrends in Pharmacological Sciences, 2006
- Melatonin receptors in humans: biological role and clinical relevanceBiomedicine & Pharmacotherapy, 2006
- The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic systemMolecular Brain Research, 2005
- A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog β-methyl-6-chloromelatoninLife Sciences, 2004
- Melatonin Reverses the Profibrillogenic Activity of Apolipoprotein E4 on the Alzheimer Amyloid Aβ PeptideBiochemistry, 2001
- Gene Regulation by MelatoninAnnals of the New York Academy of Sciences, 2000
- A relationship between heat loss and sleepiness: effects of postural change and melatonin administrationJournal of Applied Physiology, 1997